Foreign institutional money is flooding Dalal Street at a record clip.
Overseas portfolio investors purchased ₹12,563 crore worth of Indian equities on Wednesday, lifting net inflows for November to $7.3 billion in just seven trading sessions, according to provisional stock exchange data. The velocity of capital deployment averages roughly $1 billion every single trading day. If this torrential buying persists, November will shatter all previous monthly records in the history of Indian capital markets.
The shift is stark. For months, foreign allocators sat underweight on Indian equities, dumping roughly $33 billion in domestic shares during 2026 through mid-October. That defensive stance has dissolved. Plummeting crude oil prices, attractive relative valuations, and an improving domestic macroeconomic setup have triggered aggressive institutional re-allocation into Mumbai.
The current pace of foreign buying has few historical parallels. The last comparable buying tsunami took place during the pandemic rebound in late 2020, when foreign funds absorbed $9.56 billion in November and $7.27 billion in December.
Yet that 2020 run followed catastrophic panic dumping of $8.4 billion in March 2020 as global supply chains shuttered. Today's influx marks a clean departure from months of grinding capital flight.
| Month | Net FPI Equity Inflows ($ Billion) |
|---|---|
| November 2020 | $9.56 |
| November 2026 (7 Sessions) | $7.30 |
| December 2020 | $7.27 |
| December 2023 | $7.02 |
| August 2022 | $6.79 |
| June 2023 | $6.72 |
Market Context: Global allocators are actively rotating capital away from high-beta, technology-heavy East Asian exchanges. With crude oil prices softening and Indian headline indices consolidating through the first ten months of the year, domestic equities now present foreign desks with an insulated growth redoubt backed by accelerating corporate bottom lines.
Global investment banks have sprinted to adjust their portfolio allocations. HSBC, Citi, Bernstein, and CLSA have all upgraded their stance on Indian equities, pointing to sound macroeconomic stability, defensive earnings growth, and cooling market multiples.
HSBC lifted its rating on India from Neutral to Overweight. Analysts at the brokerage cited the domestic market's diversification benefits and low volatility relative to regional peers dominated by speculative artificial intelligence plays. HSBC projected consensus corporate earnings growth of 14% for FY27 and 16% for FY28, noting that large-cap valuations have returned to palatable entry zones.
Multiples have indeed compressed. At Wednesday's closing print of 25,255, the benchmark Nifty 50 traded at 18.4 times its one-year forward earnings. That sits below its five-year historical average of 19.3 times. While South Korea's Kospi trades at 3.8 times and Taiwan's Taiex commands 14.5 times forward earnings, India's earnings visibility has justified the historical premium in the eyes of returning asset managers.
The tidal wave of foreign capital has extended immediate support to the foreign exchange market. The Indian rupee crossed the critical 94-per-dollar threshold on Wednesday, settling at 93.69 against the greenback—its strongest closing level in nearly seven months. Over the past week alone, the rupee gained more than 1%, beating every other Asian currency over the same stretch.
On equity desks, foreign funds are funneling their allocations almost exclusively into top-tier blue chips. Liquid frontline counters have left broader market gauges behind. Month-to-date, the Nifty 50 has surged nearly 10%. In contrast, the Nifty Midcap index gained 7.4%, while the Nifty Smallcap index lagged behind with a 5.6% advance.
With two-thirds of the trading month still on the calendar, market participants will track whether daily institutional purchase tallies remain near the $1 billion mark, setting the stage for a run at November 2020's all-time historical peak of $9.56 billion.